A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron.
The Ewing's sarcoma cell line ICB 112 was examined in detail for a cholinergic phenotype. Choline acetyltransferase activity (12.3 +/- 2.9 nmol/h/mg of protein) was associated with the presence of multiple mRNA species labeled with a human choline acetyltransferase riboprobe. Choline was taken up by the cells by a high-affinity, hemicholinium-3-sensitive transporter that was partially inhibited when lithium replaced sodium in the incubation medium; the choline taken up was quickly incorporated into both acetylcholine and phosphorylcholine. High-affinity binding sites for vesamicol, an inhibitor of vesicular acetylcholine transport, were also present. The mRNAs for synaptotagmin (p65) and the 15-kDa proteolipid were readily detected and were identical in size to those observed in cholinergic regions of the human brain. Cumulative acetylcholine efflux was increased by raising the extracellular potassium level or the addition of a calcium ionophore, but the time course of stimulated efflux was slow and persistent. These results show that this morphologically undifferentiated cell line is capable of acetylcholine synthesis and expresses markers for synaptic vesicles as well as proteins implicated in calcium-dependent release but lacks an organized release mechanism.
O'Regan
S
S
Département de Neurochimie, CNRS, Gif-sur-Yvette, France.
Diebler
M F
MF
Meunier
F M
FM
Vyas
S
S
D000109:Acetylcholine / Q000378:metabolism; D000328:Adult; D002135:Calcium-Binding Proteins; D002794:Choline / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000032:analysis / Q000378:metabolism; D002799:Cholinergic Fibers / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000235:genetics; D009467:Neuromuscular Depolarizing Agents / Q000378:metabolism; D009474:Neurons / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D010880:Piperidines / Q000378:metabolism; D011510:Proteolipids / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012512:Sarcoma, Ewing / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D050863:Synaptotagmin I; D050857:Synaptotagmins; D014316:Tritium; D014407:Tumor Cells, Cultured; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D002135:Calcium-Binding Proteins; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D009467:Neuromuscular Depolarizing Agents; D010880:Piperidines; D011510:Proteolipids; D012333:RNA, Messenger; D050863:Synaptotagmin I; D014316:Tritium; D050857:Synaptotagmins; C006189:vesamicol; D014446:Tyrosine 3-Monooxygenase; D002795:Choline O-Acetyltransferase; D002794:Choline; D000109:Acetylcholine